對(duì)照品 > 標(biāo)準(zhǔn)品 > 歐洲藥典標(biāo)準(zhǔn)品 >
產(chǎn)品基本信息
產(chǎn)品編號(hào)：B677370
產(chǎn)品名稱：Bretylium Tosylate
產(chǎn)品CAS：61-75-6
規(guī)格含量：100mg
產(chǎn)品價(jià)格：面議
聯(lián)系我們:
產(chǎn)品詳細(xì)介紹
標(biāo)準(zhǔn)品編號(hào):
B677370
名稱:
Bretylium Tosylate
別名:
2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium 4-Methylbenzenesulfonate; (o-Bromobenzyl)ethyldimethylammonium p-Toluenesulfonate; (o-Bromobenzyl)ethyldimethylammonium p-Toluenesulfonate; ASL 603; Bretylan; Bretylate; Bretylium p-Toluenesulfonate; Bretylium Tosilate; Bretylol; Darenthin; N-Ethyl-N-(o-bromobenzyl)-N,N-dimethylammonium Tosylate; NSC 62164; Ornid;
CAS號(hào):
61-75-6
參考CAS:
Free Base: 59-41-6
分子式:
C??H??BrNO?S
外觀:
白色固體
熔點(diǎn):
90-92°C
分子量:
414.36
儲(chǔ)存:
冰箱保存
溶解度:
Chloroform (Slightly), Methanol (Slightly)
類別:
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Bretylium tosylate has a biphasic response, initially inducing norepinephrine release followed by sympathetic ganglionic blockade. Bretylium tosylate is a class III antiarrhythmic agent and a competitive inhibitor of acetylcholinesterase.
參考文獻(xiàn)
Kuntzman, R., et al.: Clin. Pharmacol. Ther., 11, 829 (1970), Goldenthal, E.I., et al.: Toxicol. Appl. Pharmacol., 18, 185 (1971), Carter, J.E., et al.: Anal. Profiles Drug Subs., 9, 71 (1980),
?您的位置：
